Terence Rabbitts

Q: What Schools Are Affiliated With Terence Rabbitts

Terence Rabbitts is affiliated with the following schools: Institute of Cancer Research, University of East Anglia, University of Leeds, University of Oxford, University of Cambridge

Terence Rabbitts's AcademicInfluence.com Rankings

Terence Rabbitts

Biology

#3102

World Rank

#4791

Historical Rank

Molecular Biology

#315

World Rank

#320

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Terence Rabbitts Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Terence Howard Rabbitts FRS FMedSci is currently Professor of Molecular Immunology at the Institute of Cancer Research, London. Education He was educated at John Ruskin Grammar School, the University of East Anglia where he graduated with a BSc with first class honours in Biological Sciences, and subsequently completed his PhD at the National Institute for Medical Research, Mill Hill, London.

(See a Problem?)

Terence Rabbitts's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 (2003) (3518)
Chromosomal translocations in human cancer (1994) (1535)
The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins (1997) (875)
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development (1994) (643)
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma (1993) (554)
An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes (1996) (527)
Two tandemly organized human genes encoding the T-cell γ constant-region sequences show multiple rearrangement in different T-cell types (1985) (395)
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. (1991) (357)
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. (1998) (345)
The LIM domain: a new structural motif found in zinc-finger-like proteins. (1994) (330)
Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing γ, ε and α genes (1982) (323)
Diversity and rearrangement of the human T cell rearranging γ genes: Nine germ-line variable genes belonging to two subgroups (1986) (316)
A hapten-specific chimaeric IgE antibody with human physiological effector function (1985) (280)
Translocations, master genes, and differences between the origins of acute and chronic leukemias (1991) (276)
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. (2004) (267)
Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. (1985) (266)
A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q (1994) (256)
Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. (1996) (235)
Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. (1994) (233)
The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal (2010) (233)
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma (1983) (233)
HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. (1991) (232)
The Mll–AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis (1999) (217)
The mechanism of chromosomal translocation t(11;14) involving the T‐cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. (1988) (217)
Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. (1995) (215)
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. (1994) (213)
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma (1984) (207)
Complexity of human T-cell antigen receptor β-chain constant- and variable-region genes (1984) (205)
Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. (1982) (199)
Selection of antibodies for intracellular function using a two-hybrid in vivo system. (1999) (194)
The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non‐allelic genes. (1982) (189)
Translocation joins c-myc and immunoglobulin γ1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene (1983) (184)
The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. (2000) (180)
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. (2014) (180)
Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. (2004) (174)
Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1 (2003) (173)
LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. (1998) (170)
Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region. (1980) (169)
The Hox11 gene is essential for cell survival during spleen development. (1995) (168)
Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. (1996) (163)
Alternating purine‐pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. (1989) (163)
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study (2021) (161)
Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. (1981) (159)
Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene (2001) (157)
Rearrangement of two distinct T-cell γ-chain variable-region genes in human DNA (1986) (155)
The use of chromosomal translocations to study human immunoglobulin gene organization: mapping DH segments within 35 kb of the C mu gene and identification of a new DH locus. (1988) (154)
Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals (1982) (151)
New subgroups in the human T cell rearranging V gamma gene locus. (1987) (151)
The role of Slit-Robo signaling in the generation, migration and morphological differentiation of cortical interneurons. (2008) (150)
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS (2007) (147)
Mechanisms of divergence and convergence of the human immunoglobulin α1 and α2 constant region gene sequences (1984) (145)
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors (1985) (145)
Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene (2000) (144)
Truncation of exon 1 from the c‐myc gene results in prolonged c‐myc mRNa stability. (1985) (141)
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. (2005) (140)
Evolution of immunoglobulin V genes: Evidence indicating that recently duplicated human Vκ sequences have diverged by gene conversion (1983) (139)
The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development (2003) (137)
Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. (2003) (134)
A rapid procedure for colony screening using nylon filters. (1989) (134)
The role of gene deletion in the immunoglobulin heavy chain switch (1980) (131)
Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation (2003) (130)
The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes. (1993) (124)
A cluster of chromosome 11p13 translocations found via distinct D‐D and D‐D‐J rearrangements of the human T cell receptor delta chain gene. (1988) (124)
The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. (2006) (122)
Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma. (1986) (121)
Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies. (2003) (114)
Inter‐chromosomal recombination of Mll and Af9 genes mediated by cre‐loxP in mouse development (2000) (110)
The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors (1989) (110)
Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. (2010) (109)
The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. (1992) (109)
A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology (2006) (106)
T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. (1992) (106)
Segmental and developmental regulation of a presumptive T-cell oncogene in the central nervous system (1990) (105)
The oncogenic T cell LIM‐protein Lmo2 forms part of a DNA‐binding complex specifically in immature T cells (1998) (105)
Structural basis for the heterodimeric interaction between the acute leukaemia‐associated transcription factors AML1 and CBFβ (2000) (102)
Molecular cloning of putative odorant-binding and odorant-metabolizing proteins. (1991) (101)
Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. (2002) (97)
The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. (1995) (97)
The cysteine‐rich LIM domains inhibit DNA binding by the associated homeodomain in Isl‐1. (1993) (96)
The chromosomal location of T‐cell receptor genes and a T cell rearranging gene: possible correlation with specific translocations in human T cell leukaemia. (1985) (93)
Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. (1994) (92)
Human immunoglobulin variable region genes—DNA sequences of two Vκ genes and a pseudogene (1980) (91)
Bacterial cloning of plasmids carrying copies of rabbit globin messenger RNA (1976) (90)
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. (1994) (89)
Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells (1984) (89)
Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia (1987) (88)
Null Mutation of the Lmo4 Gene or a Combined Null Mutation of the Lmo1/Lmo3 Genes Causes Perinatal Lethality, and Lmo4 Controls Neural Tube Development in Mice (2004) (86)
An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing (1980) (86)
Intracellular antibodies and challenges facing their use as therapeutic agents. (2003) (86)
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment (2018) (85)
Human Vκ immunoglobulin gene number: Implications for the origin of antibody diversity (1981) (83)
Sequence and evolution of the human T-cell antigen receptor beta-chain genes. (1985) (82)
Mouse Af9 Is a Controller of Embryo Patterning, Like Mll, Whose Human Homologue Fuses with AF9 after Chromosomal Translocation in Leukemia (2002) (81)
Transcription enhancer identified near the human Cμ immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma (1983) (80)
Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus (1991) (79)
Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia (1998) (78)
Complex rearrangements within the human J delta‐C delta/J alpha‐C alpha locus and aberrant recombination between J alpha segments. (1988) (78)
Human immunoglobulin VH and D segments on chromosomes 15q11.2 and 16p11.2. (1994) (77)
Immunoglobulin heavy chain genes in humans are located on chromosome 14 (1981) (77)
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds (2019) (76)
Chromosome abnormalities at 11q13 in B cell tumours (1988) (75)
Mll fusions generated by Cre‐loxP‐mediated de novo translocations can induce lineage reassignment in tumorigenesis (2005) (74)
Heterogeneity of T‐cell beta‐chain gene rearrangements in human leukaemias and lymphomas. (1985) (73)
Novel genes for potential ligand‐binding proteins in subregions of the olfactory mucosa. (1991) (73)
Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes. (1982) (72)
A human chromosome 8 region with abnormalities in B cell, HTLV‐I+ T cell and c‐myc amplified tumours. (1987) (69)
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange (2017) (68)
The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis. (1987) (67)
Physical linkage of three CD3 genes on human chromosome 11. (1987) (67)
PCRPi: Presaging Critical Residues in Protein interfaces, a new computational tool to chart hot spots in protein interfaces (2009) (66)
Commonality but Diversity in Cancer Gene Fusions (2009) (66)
Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy. (2000) (65)
The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. (1990) (64)
Epstein‐Barr virus‐transformed human precursor B cell lines: altered growth phenotype of lines with germline or rearranged but nonexpressed heavy chain genes (1987) (63)
Human T‐cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32. (1987) (63)
Targeted Disruption of the 3p12 Gene, Dutt1/Robo1, Predisposes Mice to Lung Adenocarcinomas and Lymphomas with Methylation of the Gene Promoter (2004) (62)
Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. (2013) (62)
The mechanism of chromosome 14 inversion in a human T cell lymphoma (1987) (61)
Interfering with RAS–effector protein interactions prevent RAS-dependent tumour initiation and causes stop–start control of cancer growth (2010) (60)
The chromosomal translocation t(X;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another. (1993) (60)
Membrane-bound ribosomes of myeloma cells. IV. mRNA complexity of free and membrane-bound polysomes (1981) (59)
Evidence for splicing of interrupted immunoglobulin variable and constant region sequences in nuclear RNA (1978) (59)
Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells. (2013) (58)
Chromatin structure of transcriptionally active and inactive human c‐myc alleles. (1985) (58)
LIM domain proteins in leukaemia and development. (1993) (58)
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism. (2002) (58)
An immunoglobulin heavy-chain gene is altered in two T-cell clones (1980) (58)
LMO2 at 25 years: a paradigm of chromosomal translocation proteins (2015) (58)
The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development. (1999) (57)
Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules. (2004) (56)
The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target (2002) (55)
Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. (1982) (55)
Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression. (1991) (55)
The Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells (2005) (53)
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe (2019) (53)
Chromosomal translocation master genes, mouse models and experimental therapeutics (2001) (52)
An unusual structure of a putative T cell oncogene which allows production of similar proteins from distinct mRNAs. (1990) (52)
Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia. (2003) (52)
Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism. (1984) (51)
Cysteine-rich LIM domains of LIM-homeodomain and LIM-only proteins contain zinc but not iron. (1994) (50)
Chromosomal abnormalities in lymphoid tumours: mechanism and role in tumour pathogenesis. (1988) (50)
Evidence for noncontiguous variable and constant region genes in both germ line and myeloma DNA (1978) (50)
Comparison of the hinge‐coding segments in human immunoglobulin gamma heavy chain genes and the linkage of the gamma 2 and gamma 4 subclass genes. (1982) (50)
The sequence of the human immunoglobulin mu-delta intron reveals possible vestigial switch segments. (1984) (50)
Chromosomal translocation products engender new intracellular therapeutic technologies (2003) (49)
A VH gene is located within 95 Kb of the human immunoglobulin heavy chain constant region genes (1988) (49)
Contribution of immunoglobulin heavy-chain variable-region genes to antibody diversity (1980) (49)
A chromosomal basis of lymphoid malignancy in man. (1989) (48)
DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. (1984) (48)
The T-Cell Oncogenic Protein HOX11 ActivatesAldh1 Expression in NIH 3T3 Cells but Represses Its Expression in Mouse Spleen Development (1998) (48)
Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. (1984) (47)
The human T-cell receptor ? (TRG) genes (1989) (46)
Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14q32. (1988) (45)
Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points. (1985) (45)
Intracellular antibodies and cancer: New technologies offer therapeutic opportunities (2010) (45)
Genomic structure, tissue expression and chromosomal location of the LIM-only gene, SLIM1. (1999) (44)
Molecular cloning of a zinc finger protein which binds to the heptamer of the signal sequence for V(D)J recombination. (1993) (44)
Rearrangement of the T-cell receptor delta genes in human T-cell leukemias. (1989) (43)
Protocol for the selection of single-domain antibody fragments by third generation intracellular antibody capture (2010) (42)
Alpha, beta and gamma T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias. (1987) (41)
α, β and γ T‐cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias (1987) (41)
Summary Lmo 2 and Scl / Tal 1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata 1 (2003) (41)
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS (2020) (41)
An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions (2008) (40)
Structural and functional chimerism results from chromosomal translocation in lymphoid tumors. (1991) (40)
The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11) (1998) (40)
Functional intracellular antibody fragments do not require invariant intra-domain disulfide bonds. (2008) (40)
A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia. (1991) (39)
De novo production of diverse intracellular antibody libraries. (2003) (39)
Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target (2016) (39)
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions (2018) (39)
A Complete Map of the Human Immunoglobulin VH Locus (1995) (38)
Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia. (2009) (37)
Interrogation of genomes by molecular copy-number counting (MCC) (2006) (37)
HAPPY mapping of a YAC reveals alternative haplotypes in the human immunoglobulin VH locus. (1993) (37)
T-cell leukemias with rearrangement of the gamma but not beta T-cell receptor genes. (1988) (37)
Single Domain Intracellular Antibodies from Diverse Libraries (2010) (36)
Mouse immunoglobulin genes: studies on the reiteration frequency of light-chain genes by hybridisation procedures. (1975) (36)
The invertor knock-in conditional chromosomal translocation mimic (2004) (35)
The T cell oncogene Tal2 is necessary for normal development of the mouse brain. (2000) (35)
Genetic organization of the human T-cell receptor gamma and delta loci. (1990) (34)
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. (2014) (33)
T3 delta pre‐mRNA is transcribed from a non‐TATA promoter and is alternatively spliced in human T cells. (1986) (33)
Rearrangement of two distinct T-cell gamma-chain variable-region genes in human DNA. (1986) (33)
A nomenclature to fit the organization of the human T-cell receptor gamma and delta genes. (1990) (33)
Organization of the human CD3 locus on chromosome 11 (1988) (33)
Unusual forms of T cell γ mRNA in a human T cell leukemia cell line: Implications for γ gene expression (1987) (32)
Complex rearrangements within thehuman J- CI/J.- Calocus andaberrant recombination between J.segments (1988) (31)
LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1. (1997) (31)
Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation—why are these functions targeted? (1999) (30)
Optimal Activation of an Endogenous Gene by HOX11 Requires the NH2-Terminal 50 Amino Acids (1998) (29)
The human immunoglobulin genes. The nineteenth Colworth medal lecture. (1983) (27)
Functional inhibition of β-catenin-mediatedWnt signaling by intracellular VHHantibodies (2014) (27)
Interfering with protein-protein interactions: Potential for cancer therapy (2008) (27)
A simple technique for generating probes for RNA in situ hybridization: an adjunct to genome mapping exemplified by the RAG-1/RAG-2 gene cluster. (1991) (27)
Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2. (1995) (26)
A Molecular Hybridization Approach for the Determination of the Immunoglobulin V‐Gene Pool Size (1977) (26)
Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias. (2008) (25)
Demonstration that a mouse immunoglobulin light chain messenger RNA hybridizes exclusively with unique DNA (1975) (25)
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection (2021) (25)
Chromosomal Translocations and Genome Rearrangements in Cancer (2015) (24)
Chromosomal translocation engineering to recapitulate primary events of human cancer. (2005) (24)
The breakpoint of the Philadelphia chromosome 22 in chronic myeloid leukaemia is distal to the immunoglobulin lambda light chain constant region genes. (1983) (23)
Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities (2019) (23)
Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves (2019) (22)
The human T-cell receptor gamma (TRG) genes. (1989) (20)
Leukaemia lineage specification caused by cell-specific Mll-Enl translocations (2008) (20)
Sub-proteome differential display: single gel comparison by 2D electrophoresis and mass spectrometry. (2002) (20)
Immunoglobulin VH genes are transcribed by T cells in association with a new 5' exon (1988) (20)
The clinical significance of fusion oncogenes in cancer. (1998) (19)
The c-myc gene paradox in Burkitt's lymphoma chromosomal translocation. (1984) (19)
A Drosophila melanogaster homologue of the T-cell oncogene HOX11 localises to a cluster of homeobox genes. (1994) (19)
MLL gene fusions in human leukaemias: in vivo modelling to recapitulate these primary tumourigenic events (2008) (18)
Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex (2014) (18)
Clonal evolution of malignant and non-malignant T cells carrying t(14;14) and t(X;14) in patients with ataxia telangiectasia. (1994) (18)
A HUMAN T-CELL TRANSLOCATION INVOLVING CHROMOSOME-11P15 IDENTIFIES A GENE EXPRESSED IN DEVELOPING RHOMBOMERES OF THE MOUSE HIND BRAIN (1989) (17)
Multiple methylation‐free islands flank a small breakpoint cluster region on 11p13 in the t(11;14)(p13;q11) translocation (1990) (17)
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome. (1994) (16)
Mouse models of human chromosomal translocations and approaches to cancer therapy. (2001) (16)
Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats (2020) (16)
A mouse immunoglobulin heavy chain deletion mutant: isolation of a cDNA clone and sequence analysis of the mRNA. (1980) (16)
Human Antibody Genes: V Gene Variability and CH Gene Switching Strategies (1981) (15)
Organization of the T-cell receptor alpha-chain gene and rearrangement in human T-cell leukaemias. (1986) (15)
Comparative hybridization studies with an immunoglobulin light chain mRNA fraction and non‐immunoglobulin mRNA of mouse (1974) (15)
Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs (2012) (15)
Sequence of the D2-J2 region of the human T-cell receptor -chain locus (1985) (15)
Molecular analysis of a new translocation, t(X;I4)(q28;qII), in premalignancy and in leukaemia associated with ataxia telangiectasia (1992) (15)
Unrearranged immunoglobulin variable region genes have a functional promoter. (1982) (14)
ASSIGNMENT OF A IGKV LOCUS FOR IMMUNOGLOBULIN LIGHT-CHAINS TO THE SHORT ARM OF CHROMOSOME-2 (2P13-]CEN) BY INSITU HYBRIDIZATION USING A CRNA PROBE OF H-KAPPA-101-LAMBDA-CH4A (1982) (14)
Quantitation of antibody genes by molecular hybridization. (1977) (14)
The chromosome breakpoint at 14q32 in an ataxia telangiectasia t(14;14) T cell clone is different from the 14q32 breakpoint in Burkitts and an inv(14) T cell lymphoma (1986) (14)
Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis. (1997) (14)
Hybridization characteristics of enzymatically synthesised DNA complementary to mouse immunoglobulin messenger RNA (1974) (14)
Redox regulation of in vitro DNA-binding activity by the homeodomain of the Isl-1 protein. (1993) (14)
REARRANGEMENTS OF THE C-MYC GENE IN BURKITTS-LYMPHOMA (1984) (13)
Characterization of the Lmo4 gene encoding a LIM-only protein: genomic organization and comparative chromosomal mapping (1999) (13)
Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture. (2015) (12)
LIM domains (1990) (11)
The chromosome breakpoint at 14 q 32 in an ataxia telangiectasia t ( 14 ; 14 ) T cell clone is different from the 14 q 32 breakpoint in Burkitts and an inv ( 14 ) T cell lymphoma (11)
The c-myc protein is associated with the nuclear matrix through specific metal interaction. (1987) (11)
Nonreciprocal chromosomal translocations in renal cancer involve multiple DSBs and NHEJ associated with breakpoint inversion but not necessarily with transcription (2013) (11)
Colcemid inhibits growth during early G1 in normal but not in tumorigenic lymphocytes. (1986) (10)
Selection of complementary single-variable domains for building monoclonal antibodies to native proteins (2009) (9)
LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia (2016) (9)
Molecular genetics of antigen receptors and associated chromosomal abnormalities in human leukemias. (1986) (9)
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency (2021) (9)
The mitochondrial ribosome and ribosomal RNA of the chick (1971) (9)
Turbo-screening of bacterial colonies using microwave denaturation on paper filters. (1990) (9)
Intracellular antibody capture: A molecular biology approach to inhibitors of protein-protein interactions. (2014) (9)
The variability, arrangement, and rearrangement of immunoglobulin genes. (1980) (9)
Immunoglobulin genes undergo multiple sequence rearrangements during differentiation. (1981) (9)
Human immunoglobulin variable region genes--DNA sequences of two V kappa genes and a pseudogene. (1980) (8)
Intracellular antibody capture (IAC) methods for single domain antibodies. (2012) (8)
c-myc Gene Activation and Chromosomal Translocation (1984) (8)
IMMUNOGLOBULIN GENES IN A MOUSE MYELOMA AND IN MUTANT CLONES (1975) (8)
The sequence at the 3' terminus of mouse immunoglobulin secreted mu chain messenger RNA determined from cloned cDNA. (1980) (8)
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein (2017) (8)
Reassessment of breakpoints in chromosome 11p15. (1993) (7)
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2 (2021) (7)
Human RAG2, like RAGI, is on chromosome II band p13 and therefore not linked to ataxia telangiectasia complementation groups (1992) (7)
T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity (2001) (7)
Single Domain Antibody Fragments as Drug Surrogates Targeting Protein–Protein Interactions inside Cells (2013) (7)
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model (2019) (6)
Masked antisense: a molecular configuration for discriminating similar RNA targets (2000) (6)
SUBREGIONAL MAPPING OF BWS, CTSD, MYOD1, AND A T-ALL BREAKPOINT IN 11P15 (1989) (6)
A method for identifying genes within yeast artificial chromosomes: application to isolation of MLL fusion cDNAs from acute leukaemia translocations. (1993) (6)
Salmonella-based platform for efficient delivery of functional binding proteins to the cytosol (2020) (6)
Genetic organization of the human T cell receptor gamma locus. (1991) (6)
Isolation of antigen-specific intracellular antibody fragments as single chain Fv for use in mammalian cells. (2002) (6)
Bioluminescence Resonance Energy Transfer 2 (BRET2)‐Based RAS Biosensors to Characterize RAS Inhibitors (2019) (6)
Peptides: minimal drug surrogates to interrogate and interfere with protein function (2013) (5)
Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3 (2019) (5)
Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias (2008) (5)
Breakage on chromosome 2 brings the Ck gene to a region 3' of c-myc in a Burkitt's lymphoma line carrying a (2;8) translocation. (1985) (5)
Pan RAS-binding compounds selected from a chemical library by inhibiting interaction between RAS and a reduced affinity intracellular antibody (2021) (5)
Ciba Medal Lecture. Chromosomal abnormalities in cancer cells: identification of molecules important for tumour development. (1993) (5)
Investigation of the genetic diversity of mouse immunoglobulin kappa-chain genes. (1975) (5)
DNA JUGGLING IN THE IMMUNE SYSTEM (1984) (5)
Immunoglobulin heavy chain genes in humans are located on chromosome. (1981) (5)
Sequential gene targeting to make chimeric tumor models with de novo chromosomal abnormalities. (2014) (4)
REARRANGEMENT OF THE T-CELL RECEPTOR DELTA (TCR-DELTA GENES IN HUMAN T-CELL LEUKEMIAS (1988) (4)
Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor (2018) (4)
The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis. (2003) (4)
REFINED BREAKPOINT MAP OF WAGR AND RELATED PATIENTS WITH CHROMOSOME-11P13 MARKERS (1989) (4)
Chromosomal breakpoints hit the spot (1997) (4)
Unusual forms of T cell gamma mRNA in a human T cell leukemia cell line: implications for gamma gene expression. (1987) (4)
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins (2021) (4)
GENETICS OF THE T-CELL RECEPTOR (1985) (4)
A non-cell autonomous mouse model of CNS haemangioblastoma mediated by mutant KRAS (2017) (4)
Antibody diversification by somatic mutation. (1981) (4)
Human V kappa immunoglobulin gene number: implications for the origin of antibody diversity. (1981) (3)
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells (2021) (3)
The Human T-Cell Rearranging γ Genes (TRGγ) (1988) (3)
Germline sequence of two human T-cell receptor V beta genes: V beta 8.1 is transcribed from a TATA-box promoter. (1987) (3)
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions (2018) (3)
Erratum: In the letter 'Human immunoglobulin variable region genes-DNA sequences of two VK genes and a pseudogene' (Nature (1980) 288 (730-733)) (1981) (3)
Selection of functional single domain antibody fragments for interfering with protein-protein interactions inside cells: a "one plasmid" mammalian two-hybrid system. (2012) (3)
Localization of human immunoglobulin K light chain variable region genes to the short arm of chromosome 2 by in situ hybridization ( human K genes / gene mapping / chromosome translocation / Burkdtt lymphoma ) (3)
The human T-cell receptor 7 (TRG) genes (1989) (2)
RHOM-3, A GENE WHICH IS HIGHLY RELATED TO RHOMBOTIN AND LOCATED ON CHROMOSOME-12P13 (1991) (2)
Antibody diversity — How many antibody genes? (1976) (2)
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma (2017) (2)
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds (2021) (2)
Protocols for isolating antigenspecific intracellular antibody fragments as single chain Fv for use in mammalian cells. (2001) (2)
Sequence of the D beta 2-J beta 2 region of the human T-cell receptor beta-chain locus. (1985) (2)
Corrigendum: Interrogation of genomes by molecular copy-number counting (MCC) (2006) (2)
Discussion on the metabolism of c-myc mRNA and protein (1985) (2)
Immunoglobulin mRNA and Immunoglobulin Genes (1976) (2)
The nineteenth Colworth Medal Lecture. The human immunoglobulin genes. (1983) (2)
Cytogenetics and molecular biology combine in the investigation of chromosomal translocation and human leukaemia. (1983) (2)
Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells. (2020) (2)
Of methods and mapping (1999) (2)
TRANSCRIPTION FACTORS AND CHROMOSOMAL TRANSLOCATIONS IN LEUKEMIA (1993) (1)
Transcription factor interactions that influence hematopoiesis and leukemia (1999) (1)
The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis (2021) (1)
Structure and Arrangement of Human Heavy Chain Variable Region Genes (1981) (1)
Human T-cell receptor -chain genes (1985) (1)
Association of erythroid transcription factors : Complexes involving the LIM protein RBTN 2 and the zinc-finger protein GATAl ( erythropoiesis / transcription / leukemia / translocation ) (2005) (1)
Human T-cell receptor beta-chain genes. (1985) (1)
Immunoglobulin VH‐T cell receptor Cα fusion mRNA resulting from chromosome inversion include the T cell‐associated 5′ exon ET (1992) (1)
IMMUNOGLOBULIN GENE REARRANGEMENT IN LYMPHOCYTIC-LEUKEMIA (1984) (1)
DNA in medicine DNA juggling in the immune system (1984) (1)
IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE REARRANGEMENT IN CASES OF ACUTE MYELOID-LEUKEMIA (1988) (1)
A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins. (2022) (1)
The erythroid, LIM-only protein LMO2 forms a DNA-binding complex with TAL1, E2A and GATA-1. (1996) (1)
ETV6: Its Role in Mouse Development and Leukaemogenesis Using Knock-Out and Knock-In Models. (2007) (1)
The mitochondrial ribosome of baby-hamster kidney cells. (1971) (1)
LMO2 is critical for early metastatic events in breast cancer (2021) (1)
Author response: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions (2018) (0)
GENE FUSION AND REARRANGEMENTS IN HUMAN LEUKEMIAS (1986) (0)
Evolutionary diversification of germ-line versions of human immunoglobulin genes. (1984) (0)
RBTN AND HOX11 GENES - PARADIGMS OF TRANSLOCATION JUNCTION GENES IN CHILDHOOD T-CELL ACUTE-LEUKEMIA (1993) (0)
Human KRAS in complex with darpin K27 (2017) (0)
ORGANIZATION, DIVERSITY AND REARRANGEMENT OF THE HUMAN T-CELL REARRANGING GAMMA-GENES (1986) (0)
Antibody derived (Abd-4) small molecule binding to KRAS. (2018) (0)
Human antibody genes in normal and abnormal lymphocytes. (1983) (0)
Protein dimerization betweenLmo2 (Rbtn2)and Tallalters thymocyte development andpotentiates Tcell tumorigenesis intransgenic mice (1996) (0)
Target Sequences and Accessibility for Chromosomal Translocations Involving T-Cell Receptor Genes (1990) (0)
P395: PHARMACEUTICAL TARGETING OF RAS IN ACUTE MYELOID LEUKAEMIA (2022) (0)
César Milstein October 8, 1927– March 24, 2002 (2002) (0)
Correction of SCID-XI by gene transfer: Current state and future plans. (2003) (0)
Recombinant single-cycle influenza virus as a new tool to augment antitumour immunity with immune checkpoint inhibitors (2021) (0)
Crystal structure of LMO2 and anti-LMO2 VH complex (2014) (0)
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment (2018) (0)
HUMAN IMMUNOGLOBULIN GENE ARRANGEMENT AND DIVERSITY (1981) (0)
The HOXJI gene encodes a DNA-binding nuclear transcription factor belonging to a distinct family of homeobox genes ( homeodomain / T-ceUl leukemia / chromosome translocation ) (2005) (0)
A Fusion Gene of Immunoglobulin and T cell Receptor DNA Segments in a Chromosome 14 Inversion of T-cell Leukaemia (1986) (0)
CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (disulfide free mutant) COMPLEX (2008) (0)
Human IgD, the Gene and the Protein (1982) (0)
Changing the Subcellular Location of the Oncoprotein Bcr-Abl Using Rationally Designed Capture Motifs (2011) (0)
Nucleic Acids Research (0)
KRAS full length G12D GPPNHP (2019) (0)
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein (2017) (0)
Chromosomal translocations and their consequences for cancer development and therapeutics (2012) (0)
The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis (2022) (0)
THE RHOM-2 GENE, HOMOLOGOUS TO RHOMBOTIN, IS AT 11P13 AND IS INVOLVED IN THE COMMON T-ALL TRANSLOCATION T(11-14)(P13-Q11) (1991) (0)
Human KRAS in complex with darpin K13 (2019) (0)
Crystal structure of HRAS(G12V) - anti-RAS Fv complex (2007) (0)
Antibody derived (Abd-6) small molecule binding to KRAS. (2018) (0)
Crystal structure of human RAS in complex with darpin K55 (2017) (0)
HOX-11, THE 1ST HOMEOBOX T-CELL ONCOGENE IS AT THE T(10,14) AND T(7,10) JUNCTION (1991) (0)
British Association for Cancer Research/ Association of Cancer Physicians/ Leukaemia Research Fund Joint Winter Meeting on Leukaemia and Lymphomas. 11-12 December 1989. Abstracts. (1990) (0)
Application of a Method for Engineering Multivalent Antibodies to Substantially Enhance Functional affinity of Clinical Trial Anti-SARS-CoV-2 Antibodies (2021) (0)
Primary-sequence changes in the differentiation of immunoglobulin genes. (1979) (0)
Searching for new oncogenes at the junctions of tumour specific chromosomal abnormalities (1987) (0)
Mitelman 4, volumes 2: Catalog of Chromosome Aberrations in Cancer (4th edn) by Felix Mitelman Wiley-Liss, 1991. $250.00 (xxxiv + 1987 pages; 2 vols) ISBN 0 471 56087 1 (1992) (0)
KRAS-169 Q61H GPPNHP + PPIN-2 (2019) (0)
Analysis of a T-cell tumor-specific breakpoint cluster at human chromosome 14 q 32 ( inversion 14 / translocation 14 / ataxia-telangiectasia / T-cell leukemia / 14 q 32 . 1 proximal locus ) (0)
An STS in the human T-ALL breakpoint cluster region (T-ALLbcr) located at 11p13. (1990) (0)
Tumor Necrosis Factor (TNF) (2001) (0)
A method of determining the copy number (2007) (0)
FUNCTIONAL, PHENOTYPIC AND MOLECULAR-BIOLOGICAL ANALYSIS OF TISSUE-INFILTRATING T-LYMPHOCYTES, WITH RESPECT TO PRIMARY BILIARY-CIRRHOSIS (1987) (0)
Transcriptional activation by TALl and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities ( T-cell acute lymphoblastic leukemia / fusion proteins / DNA binding / solid tumors / activation domain ) (0)
The origins and programming of adult and embryonic blood in xenopus and zebrafish. (2003) (0)
César Milstein: October 8, 1927– March 24, 2002 (2002) (0)
LYMPHOID NEOPLASIA ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia (2014) (0)
Interaction of the novel LIM domain binding factor Ldbl with LIM homeodomain and LMO proteins (1997) (0)
ORGANIZATION AND REARRANGEMENT OF HUMAN T-CELL REARRANGING GAMMA-GENES (1987) (0)
HUMAN-IMMUNOGLOBULIN-VH AND HUMAN-IMMUNOGLOBULIN-D SEGMENTS LOCATED ON 15Q11.2 AND 16P11.2 (1994) (0)
Crystal structure of antibody bound to viral protein (2017) (0)
Preventing HIV Infection by Binding LEDGF with an Intracellular Antibody that Mimics HIV Integrase (2018) (0)
Chromosomal translocations involving the T-cell receptor delta chain locus and two loci on the short arm of chromosome 11. (1989) (0)
Intracellular Antibodies for Drug Discovery and as Drugs of the Future (2023) (0)
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe (2019) (0)
The T Cell Receptor α Chain and Immunoglobulin Genes in Specific Chromosomal Translocations in Human Leukaemias (1986) (0)
Abstract LB-068: From intracellular antibody fragments to small molecule inhibitors of mutant KRAS (2017) (0)
Antibody derived (Abd-8) small molecule binding to KRAS. (2018) (0)
NMR waterLOGSY as An Assay in Drug Development Programmes for Detecting Protein-Ligand Interactions-NMR waterLOGSY. (2020) (0)
Pre-clinical Modelling of Chromosomal Translocations and Inversions (2015) (0)
Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis. (2022) (0)
HIV Integrase Binding Domain of Lens Epithelium-Derived Growth Factor (2018) (0)
Molecular immunology of antibodies and T cell receptors. (1987) (0)
A process for the determination of the copy number (2007) (0)
KRAS-169 Q61H GPPNHP + CH-1 (2019) (0)
KRAS-169 Q61H GPPNHP + PPIN-1 (2019) (0)
Transcription factors activated by chromosomal translocations in human cancer (1993) (0)
Unrearranged immunoglobutin variable region genes hare a functional promoter (1982) (0)
Chromosomal Abnormalities Involving the Short Arm of Chromosome 11 (Special Lecture) (1990) (0)
Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method. (2018) (0)
Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3 (2019) (0)
Potential Z-DNA between exons of human secreted and membrane immunoglobulin heavy-chain μ-gene (1984) (0)
Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene y ( T-celi antigen receptor / gene conversion / exon duplication ) (0)
KRAS full length wild-type GPPNHP (2019) (0)
Genetic arrangement in eukaryotic DNA (1975) (0)
Molecular biology, target identification and new therapeutics (2002) (0)
THE COMPLETE MAP OF THE HUMAN VH LOCUS - SEQUENCE AND STRUCTURAL DIVERSITY OF V(H) GENES (1994) (0)
Targeted Gene Disruption Demonstrates a Major Role for the LIM Domain Oncogenic Protein RBTN2 in Haematopoiesis (1994) (0)
Antibody derived (Abd-5) small molecule binding to KRAS. (2018) (0)
Anticorps anti-ras activee (2003) (0)
HEMATOPOIESIS AND STEM CELLS Distinct pathways regulated by menin and by MLL 1 in hematopoietic stem cells and developing B cells (2013) (0)
LMO Family of LIM-Only Genes (2013) (0)
Events in the Joining of Immunoglobulin V- and C-Genes (1978) (0)
DEVELOPMENTALLY REGULATED GENES AND CHROMOSOME-ABNORMALITIES IN HUMAN LYMPHOID MALIGNANCIES (1990) (0)
CHROMOSOMAL-ABNORMALITIES AND LEUKEMIA - INTRODUCTION (1993) (0)
Antibody derived (Abd-7) small molecule binding to KRAS. (2018) (0)
A VIEW OF THE CURRENT STATUS OF POSSIBLE SOMATIC VARIATION OF IMMUNOGLOBULIN GENES (1980) (0)
Human KRAS in complex with darpin K19 (2019) (0)
ONCOGENES AND CHROMOSOMAL TRANSLOCATIONS - THE ROLE OF RNTN2 IN TRANSCRIPTION, IN T-CELL ACUTE-LEUKEMIA AND IN ERYTHROPOIESIS (1995) (0)
The LMO2 Master Gene; Its Role as a Transcription Regulator Determining Cell Fate in Leukemogenesis and in Hematopoiesis (2002) (0)
Erratum: Interrogation of genomes by molecular copy-number counting (MCC) (Nature Methods (2006) vol. 3 (447-453)) (2006) (0)
KRAS full length G12V GPPNHP (2019) (0)
Disrupted expression of the c-myc oncogene in Burkitt's lymphoma (1985) (0)
The selection of single-domain antibody fragments (iDAbs) by intracellular antibody capture in yeast (2018) (0)
THE HOX11 GENE ENCODES A DNA-BINDING TRANSCRIPTION FACTOR BELONGING TO A NEW FAMILY OF HOMEOBOX GENES (1994) (0)
Crystal structure of human RAS in complex with darpin K27 (2017) (0)
A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS (2020) (0)
Genomic array analysis of renal cell carcinoma (2002) (0)
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model (2019) (0)

This paper list is powered by the following services:

Other Resources About Terence Rabbitts

en.wikipedia.org

What Schools Are Affiliated With Terence Rabbitts?

Terence Rabbitts is affiliated with the following schools:

Terence Rabbitts's Academic­Influence.com Rankings